The Avanti Group believes Med- Tech innovations encourage future investment as robotic surgical devices win with legal approval.
Intuitive Surgical makes robotic ‘surgeons’ that are regularly in use in prostate, hysterectomy and other surgical procedures. The company defended itself and set a precedent by a winning a case brought against them for claims of injuries allegedly caused by the robotic ‘surgeons’ work.
The Avanti Group noted that a jury in Washington State recently cleared the company and its da Vinci Surgical System, from any culpability in the death of Fred Taylor. Fred, who underwent several procedures after the robotic surgery unfortunately, met his demise some four years later leading to the attempt to place blame on the machine’s work. Rejection by a jury has renewed faith in this now established field.
“We are advising investors that this action is a sign of the legal overcast clearing in relation to high tech medical innovations under development or testing. These companies have been identified to offer solid gains in the future. Now is the right time to make moves leading to substantial profits,” said Michael Johnson, the Head of Investment Analysis at The Avanti Group.
The Sunnyvale, California based company has made $2.2 billion in revenue last year and received almost all the funds from its da Vinci Surgical System and products. The system was originally developed under a U.S. Army contract to build a system for remote-controlled battlefield surgery. Intuitive Surgical robot was authorized for use in 2000, and their products are still the only robotic systems with U.S. approval in soft-tissue procedures including general, gynecological and prostate operations. The robots, which cost about $1.5 million to build an individual unit, have been used in over a half million operations just within the past two years.
Intuitive Surgical shares rose significantly after news of the jury verdict broke, a sign that the concerns over the case weighing on the stock have lifted. In robo-surgery, the surgeon peers into a video game-style console several feet away, foot pedals and hand controls allow the Doctor, who is able to see through a 3D camera, control robot arms equipped with surgical tools.
“There are a number of high tech companies who will benefit directly from this news along with a number that stand to see increases, generally from more confidence in Med-Tech’s innovative new technologies. Advising investors to join with these companies identified through our research is our goal, achieving returns to be proud of from analysis and action,” said Michael Johnson, the Head of Investment Analysis at The Avanti Group.
The Avanti Group is an equity research house providing research and analysis outsourcing solutions for institutional financial traders worldwide, founded in early 2003.